Skip to main
ODT
ODT logo

Odonate Therapeutics (ODT)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Odonate Therapeutics (ODT) Stock

About Odonate Therapeutics (ODT)

Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
Market cap$54.85B
Today's volume1
Revenue (TTM)
Avg. daily volume
EBITDA (TTM)
Open$50,000
Price / earnings ratio
Today's range$150K - $150K
Debt / equity
52 week range$22.01K - $176.04K
5 year debt / equity
Beta (LTM)-2.63x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 10, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 13, 2025, the market cap for ODT stock is $54.85B

The 52-week high for ODT stock is $176,040. The current ODT stock price $undefined is 100.00% below its 52-week high

The 52-week low for ODT stock is $22,005. The current ODT stock price $undefined has increased 100.00% from its 52-week low

No, the ODT stock does not pay dividends to its shareholders

How to buy ODT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ODT stock

    Navigate to the Explore page. Then, type ODT into the search bar. When you see ODT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ODT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Odonate Therapeutics Stock Earnings

The value each ODT share was expected to gain vs. the value that each ODT share actually gained.

Odonate Therapeutics (ODT) reported Q2 2021 earnings per share (EPS) of -$0.58, missing estimates of -$0.33 by 75.76%. In the same quarter last year, Odonate Therapeutics's earnings per share (EPS) was -$1.09. Odonate Therapeutics is expected to release next earnings on 11/10/2021, with an earnings per share (EPS) estimate of $0.

Buy Odonate Therapeutics (ODT) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.